Grant of Options
RNS Number : 7183MEnSilica PLC17 July 202617 July 2026
EnSilica plc
("EnSilica" or the "Company")
Grant of options to executive directors and management
EnSilica (AIM: ENSI), a leading fabless microchip maker with a growing portfolio of reusable IP, serving the Space and Communications, Industrial, and Automotive markets, announces that the Company's Remuneration Committee has approved the grant of options over ordinary shares of 0.1p each in the Company ("Ordinary Shares") under the Company's Long Term Incentive Plan 2022 (the "LTIP") to the Company's Executive Directors and members of the senior management team (the "Options").
The Options are intended to align the interests of the Company's Executive Directors and members of the senior management team with those of shareholders by incentivising the delivery of sustained long-term growth in earnings and shareholder value.
In addition to the Options, the board of directors of EnSilica (the "Board" or the "Directors") will continue to grant equity awards to key employees under its broader employee incentive arrangements. The Board believes that broad employee participation in equity incentive schemes helps align employees' interests with those of shareholders and supports the attraction, motivation and retention of skilled talent across the business.
Further details of the Options
The Options will ordinarily vest following the announcement of the Company's results for the financial year ending 31 May 2029 ("FY2029"), subject to, inter alia, the achievement of demanding performance conditions and continued employment. Where the threshold performance conditions are not achieved at the initial three-year testing date, the Options will remain capable of vesting following the announcement of the Company's results for the financial year ending 31 May 2030 ("FY2030"), subject to the achievement of higher performance targets.
Performance will be measured equally against two independent metrics:
1) EBITDA - 50% of the Options are based on adjusted EBITDA targets, whereby 25% of these Options will vest when underlying adjusted EBITDA reaches £10.0 million for FY2029 (increasing to £12.0 million at the FY2030 testing date), with full vesting of these Options requiring adjusted EBITDA of £13.0 million for FY2029 (or £15.0 million for FY2030); and
2) Total Shareholder Return ("TSR") - 50% of the Options are based on TSR targets, measured by reference to the Company's average share price over the 20 trading days from the announcement of the relevant annual results. Vesting will commence as to 25% of these Options only if the average share price reaches 150 pence at the FY2029 testing date (or 172 pence at the FY2030 testing date), with full vesting of these Options requiring an average share price of 200 pence for the FY2029 testing date (or 252 pence for the FY2030 testing date).
Between the minimum and maximum performance thresholds, vesting of the Options will occur on a straight-line basis from 25% to 100%.
In addition, for any Options that vest and are exercised, 50% of the shares acquired will be subject to a mandatory one-year holding period (net of applicable tax liabilities), further reinforcing the alignment of management's interests with those of shareholders over the longer term.
Pursuant to the terms of the LTIP, each Option has an exercise price of 0.1p per share, being the nominal value of the Company's ordinary shares.
The Options are subject to the customary provisions of the LTIP, including malus and clawback, leaver provisions and the discretion of the Remuneration Committee in appropriate circumstances.
Executive Director Options
Of the Options granted, 2,166,000 have been granted to the Executive Directors of the Company as set out below:
Name
Role
Number of new Options granted
Number of existing options held
Total number of options now held
Mark Hodgkins
Chairman
393,000
1,515,000
1,908,000
Ian Lankshear
Chief Executive Officer
1,212,000
3,015,000
4,227,000
Kristoff Rademan
Chief Financial Officer
561,000
128,625
689,625
The table at the end of this announcement, which is provided in accordance with the requirements of the UK Market Abuse Regulation, provides further details.
There is now a total of 10,188,526 options over new Ordinary Shares granted to directors and employees of the Company.
For further information please contact:
EnSilica plc
Ian Lankshear, Chief Executive Officer
Kristoff Rademan, Chief Financial Officer
via Novella Communications
+44 (0)20 3151 7008
Allenby Capital Limited (Nominated Adviser & Joint Broker)
Jeremy Porter / Vivek Bhardwaj (Corporate Finance)
Joscelin Pinnington / Tony Quirke (Sales & Corporate Broking)
+44 (0)20 3328 5656
info@allenbycapital.com
Panmure Liberum Limited (Joint Broker)
Edward Mansfield / Will King / Zak Wadud (Corporate Finance)
Rupert Dearden / Rauf Munir (Corporate Broking)
+44 (0)20 3100 2000
Novella Communications (Investor & Financial Public Relations)
Tim Robertson / Oliver Norton
+44 (0)20 3151 7008
ensilica@novella-comms.com
About EnSilica plc
EnSilica is a fabless, application-specific chipmaker, combining deep domain and system-level expertise with world-class capability in RF, mmWave, mixed-signal and complex digital IC design. The Company serves customers across the space and communications, industrial, and automotive markets, where safety, security and reliability are critical.
A growing portfolio of reusable IP and silicon platforms underpins a repeatable, scalable delivery model, reducing development risk, cost and time to market while supporting long-term supply revenues. EnSilica has a strong track record of delivering production-proven silicon to demanding industry standards. Headquartered near Oxford, UK, the Company operates design centres across the UK, India, Brazil and Hungary.
LEI: 213800R6VXRU7MJTAF04
Information required under the UK Market Abuse Regulation:
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mark Hodgkins
Chairman
Ian Lankshear
Chief Executive Officer
Kristoff Rademan
Chief Financial Officer
2
Reason for the notification
a)
Position/status
See 1(a) above
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
EnSilica plc
b)
LEI
213800R6VXRU7MJTAF04
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.1p each in EnSilica plc ("Ordinary Shares")
ISIN: GB00BN7F1618
b)
Nature of the transaction
Grant of options over Ordinary Shares under the EnSilica plc Long Term Incentive Plan 2022
c)
Price(s) and volume(s)
Name
Volume
Exercise price
Mark Hodgkins
393,000
0.1 pence
Ian Lankshear
1,212,000
0.1 pence
Kristoff Rademan
561,000
0.1 pence
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
16 July 2026
f)
Place of the transaction
Outside of a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHGPUWPMUPQGRQ
